TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CINGULATE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

CINGULATE

ST13

US500000088514366

Class

42

Filing

88514366

Registration

6397240

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

34

Latest update

06/23/2026

Classification

Registered

Trademark type

Word

Nice classes

42

Filing date

07/15/2019

Registration date

06/22/2021

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/22/2021

Last transaction

06/23/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

08/30/2018

First use in commerce

08/30/2018

Drawing code

4

Owner type

16

Owner location

Kansas City, KS, US

Examiner

FAIRBANKS, RONALD L

Law office

N10

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Cingulate Therapeutics LLC

Representatives

Susan Neuberger Weller MINTZ, LEVIN, COHN, FERRIS, GLOVSKY AND POPEO, P.C

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Research and development services in the field of pharmaceuticals; conducting clinical trials for others in the field of pharmaceuticals

Publications

History of USPTO decisions and trademark events.

34 publications found

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

06/22/2026

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/20/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/20/2021

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/20/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

06/22/2021

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

05/15/2021

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

05/14/2021

SUPC

STATEMENT OF USE PROCESSING COMPLETE

04/26/2021

IUAF

USE AMENDMENT FILED

04/21/2021

EISU

TEAS STATEMENT OF USE RECEIVED

04/21/2021

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

03/25/2021

EX1G

SOU EXTENSION 1 GRANTED

03/24/2021

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

03/24/2021

NREV

NOTICE OF REVIVAL - E-MAILED

01/23/2021

TPEX

SOU EXTENSION RECEIVED WITH TEAS PETITION

01/22/2021

PETG

PETITION TO REVIVE-GRANTED

01/22/2021

PROA

TEAS PETITION TO REVIVE RECEIVED

01/22/2021

MAB6

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

11/23/2020

ABN6

ABANDONMENT - NO USE STATEMENT FILED

11/23/2020

EXT1

SOU EXTENSION 1 FILED

10/21/2020

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

04/21/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/25/2020

PUBO

PUBLISHED FOR OPPOSITION

02/25/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/05/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/23/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/16/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/15/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/15/2020

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

10/11/2019

GNRT

NON-FINAL ACTION E-MAILED

10/11/2019

CNRT

NON-FINAL ACTION WRITTEN

10/11/2019

DOCK

ASSIGNED TO EXAMINER

09/30/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/19/2019

NWAP

NEW APPLICATION ENTERED

07/18/2019

Continuous trademark protection

Get notified about every new filing that threatens CINGULATE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.